Methylphenidate Inhibits the Development of Myopia by Altering Dopamine and Norepinephrine Reuptake
MPH suppresses experimental myopia, with its effects linked to increased extracellular levels of DA and NE. These findings align with the anti-myopic effects observed in clinical studies, supporting a role for DA in human myopia and suggesting that NE may also contribute to the regulation of ocular growth.
Authors
- Ian G. Morgan (ORCID: https://orcid.org/0000-0002-4548-3574)
- Cindy Karouta (ORCID: https://orcid.org/0000-0003-1157-2840)
- Regan Ashby (ORCID: https://orcid.org/0000-0002-8027-6490)
- Kate Thomson (ORCID: https://orcid.org/0000-0002-2272-2800)
- Lauren Booth
Institutions
- Australian National University (AU)
- University of Canberra (AU)
Publication Details
- Journal
- Investigative Ophthalmology & Visual Science
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1167/iovs.66.12.52
- Citations
- 3
- Primary Topic
- Ophthalmology and Visual Impairment Studies
- Type
- article
- Field-Weighted Citation Impact
- 4.06